How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Dog Joint Implant Market
- By Implant Type: Total Hip Replacement Implants, Partial Hip Replacement Implants, Knee Joint Replacement Implants, Elbow Joint Replacement Implants, Shoulder Joint Replacement Implants
- By Material Type: Cobalt-Chromium Alloys, Titanium Alloys, Polyethylene, Ceramic Components, Stainless Steel
- By Surgical Technique: Cemented Implantation, Cementless Implantation, Hybrid Implantation
- By End User: Veterinary Hospitals, Specialty Orthopedic Clinics, Animal Rehabilitation Centers
- By Application: Osteoarthritis Treatment, Trauma and Fracture Repair, Congenital Joint Disorders, Degenerative Joint Disease
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Total Hip Replacement Implants leads By Implant Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Dog Joint Implant Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Arthrex Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Kyon AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Intrauma S.p.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Bionnovation LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Veterinary Orthopedic Implants (VOI)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →OrthoPets
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioMedtrix Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MediVet Biologics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Anivive Lifesciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →VetStent
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Orthomed
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Total Hip Replacement Implants41.5
- Partial Hip Replacement Implants15.2
- Knee Joint Replacement Implants13.5
- Elbow Joint Replacement Implants10.8
- Shoulder Joint Replacement Implants19.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Arthrex Inc.17.6
- Kyon AG15.4
- Intrauma S.p.A.5.5
- Stryker Corporation12.0
- Medtronic plc10.1
- DePuy Synthes (Johnson & Johnson)11.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe22.4
- Asia Pacific22.2
- Latin America13.6
- Middle East and Africa10.5
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Arthrex Inc. | 87 | 80 | 75 | 83 | 97 | 86 | 85 |
| Kyon AG | 75 | 88 | 69 | 68 | 89 | 85 | 79 |
| Intrauma S.p.A. | 80 | 74 | 67 | 65 | 72 | 78 | 73 |
| Stryker Corporation | 64 | 65 | 79 | 71 | 70 | 75 | 71 |
| Medtronic plc | 64 | 54 | 74 | 68 | 59 | 69 | 65 |
| DePuy Synthes (Johnson & Johnson) | 48 | 46 | 58 | 67 | 62 | 53 | 56 |
| Bionnovation LLC | 48 | 40 | 46 | 60 | 51 | 65 | 52 |
| Veterinary Orthopedic Implants (VOI) | 54 | 53 | 45 | 59 | 39 | 59 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Arthrex Inc.
- Kyon AG
- Intrauma S.p.A.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Arthrex Inc. | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Kyon AG | − | ✓ | ◐ | ✓ | ✓ | ✓ |
| Intrauma S.p.A. | ◐ | ✓ | ◐ | − | ✓ | ◐ |
| Stryker Corporation | − | ✓ | ◐ | − | ✓ | ✓ |
| Medtronic plc | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| DePuy Synthes (Johnson & Johnson) | ◐ | − | ◐ | − | ✓ | ◐ |
| Bionnovation LLC | ◐ | − | ◐ | ◐ | − | ◐ |
| Veterinary Orthopedic Implants (VOI) | ◐ | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche3
Specialists in a single segment or region.
Go-to-market strategy
Land Implant Type in North America, then scale across Dog Joint Implant Market — a $499M beachhead inside a $7.44B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Total Hip Replacement Implants
Best fit — highest urgency & budget in Implant Type.
Partial Hip Replacement Implants
Strong fit — clear ROI and a fast path to value.
Knee Joint Replacement Implants
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Implant Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Surgical Technique
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Implant Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Dog Joint Implant Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Dog Joint Implant Market is a high-growth opportunity — $5.21B by 2033, compounding at 10.7%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.7% CAGR
Demand compounds through 2033, outpacing GDP across Implant Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Implant Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Dog Joint Implant Market — a $1.93B market by 2033. Plan: grow share from 10.7% to 18.9%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.7% | 18.9% | On track |
| Revenue | $197M | $366M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.2% | 41.0% | At risk |
| Customer retention | 91.8% | 94.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Implant Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Material Type capability
A defensible second engine — invest in Material Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Implant Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $52M capacity & capability investment
- Greenlight bolt-on M&A in Material Type
- Authorise North America expansion plan
- Fund R&D program for Implant Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Sales deck · value proposition
Win the Dog Joint Implant Market conversation — a $3.56B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Implant Type
Goal Grow share in Implant Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Dog Joint Implant Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Dog Joint Implant Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Manganous Fluoride Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportHPMCAS Market
Market size, share, segmentation and regional forecast.
$358M market · 2025 base year
View reportDog Flea and Tick Treatment Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportLaurocapram Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportDog DNA Test Service Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportDog DNA Test Market
Market size, share, segmentation and regional forecast.
$796M market · 2025 base year
View reportDog DNA Test Kit Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportDog Deworming Medicine Market
Market size, share, segmentation and regional forecast.
$644M market · 2025 base year
View reportPodophyllotoxin Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportDog Dental Care Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBambuterol Hydrochloride CAS 81732 46 9 Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportButafosfan Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy